BodyGuardian Respiration and Activity Validation Testing

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project will compare BodyGuardian (BG) device measurements of breathing and activity levels to the gold standard measurement techniques of gas exchange using a mouthpiece connected to flow and gas analyzers measures for breathing and metabolic rate (indirect calorimetry) for activity, We are hopeful these comparisons will help us improve upon the measurements being made in the current version of the BG device.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.

NCT00556426

Pulmonary Embolism Venous Thromboembolic Disease

COMPLETED NA

Calorie Balance Monitoring and Analysis of Body Composition and Hydration Status

NCT00823329

Energy Metabolism Energy Expenditure Body Composition +1 more

SUSPENDED EARLY_PHASE1

OM2 Abbreviated Sensor Verification

NCT06415799

Hypoxia

COMPLETED

InBody Validation Study

NCT02635958

Validation Study

COMPLETED

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

NCT06402318

COVID-19 SARS CoV 2 Virus COVID-19 Pneumonia +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

BodyGuardian remote monitoring system is an FDA 510 cleared device used to perform remote monitoring of cardiac patients. BodyGuardian (BG) is a novel remote care platform. It incorporates an adhesive strip sensor with in-built electrodes attached to a rechargeable module that can determine an ECG signal and bio impedance. The module also has a 3-way accelerometer. ECG, physical activity and respiration can be assessed using these sensors. Although ECG data is reliable, there are doubts regarding the clinical meaning and validity of the activity and respiration data.

The BG reports respiration rate and activity level (on a scale of 0 to 100). This data is being used as input into other clinical algorithms including onboard ECG arrhythmia detection as well as clinical care algorithms for heart failure decompensation prediction.

Respiration data is not uniformly reported and there is still doubt regarding its validity. BG breathing measurements will be compared to gold standard measurement techniques of gas exchange using a mouthpiece connected to flow and gas analyzer. Activity data is reported but the investigators do not know how the value translates into clinically used objective parameters of activity e.g. METS. BG activity measurements will be compared to the gold standard activity measurements using metabolic rate (indirect calorimetry)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers

Healthy volunteers between the ages of 18 and 80 will wear BodyGuardian remote monitoring system to help validate respiration and activity levels.

BodyGuardian

Intervention Type DEVICE

BodyGuardian (BG) device will be worn by all subjects to determine accuracy of respiration and activity levels monitored by BG

Heart Failure

Heart failure patients between the ages of 18 and 80 will wear BodyGuardian remote monitoring system to help validate respiration and activity levels.

BodyGuardian

Intervention Type DEVICE

BodyGuardian (BG) device will be worn by all subjects to determine accuracy of respiration and activity levels monitored by BG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BodyGuardian

BodyGuardian (BG) device will be worn by all subjects to determine accuracy of respiration and activity levels monitored by BG

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy Volunteers between the ages of 18-80
* Heart Failure Patients/ Volunteers between the ages of 18-80

Exclusion Criteria

* Healthy - Non Ambulatory. With Pacemaker. Not able to sign consent.
* Hospitalized in last 6 months for fractures, myocardial infarcts, cancer related surgery, chemo therapy. Allergies to silicone or acrylic hydrogel adhesives, fragile skin, and/or pregnancy
* Heart Failure - Non Ambulatory. With Pacemaker. Not able to sign consent.
* Hospitalized in last 6 months for fractures, cancer related surgery, chemo therapy.
* Allergies to silicone or acrylic hydrogel adhesives, fragile skin, and/or pregnancy.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes